K-numberK240461
Device nameOsteoSinter® EVANS and COTTON wedges and related accessories
ApplicantAmes Medical Prosthetic Solutions, S.A.U.
Product codePLF
Device classClass II
Decision dateDec 6, 2024
DecisionSubstantially Equivalent
Regulation888.3030
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The OsteoSinter® EVANS and COTTON wedges are sterile, single-use porous titanium implants designed for internal bone fixation of foot fractures, fusions, and osteotomies. They are indicated for specific foot procedures including opening wedge osteotomies for hallux valgus, medial cuneiform/cotton osteotomies, lateral column lengthening, and metatarsal/cuneiform arthrodesis, used with ancillary bone fixation and not for spinal applications.

Technological characteristics

The subject device uses powder metal sintering technology to create a porous CP titanium wedge with 62-66% total porosity, pore cell sizes averaging 532 µm, interconnected pores averaging 270 µm, and an apparent elastic modulus of 2.8 GPa. Performance testing showed static/dynamic compressive strength, abrasion resistance of 0.32% weight loss at 1000 N, friction coefficient of 1.22±0.28, and compressive fatigue limit exceeding 11.3 MPa at 5 million cycles without failure.

Test standards cited

Not stated in this summary. The document references bench performance tests including static compressive strength, dynamic compressive strength, abrasion, and friction testing, along with biocompatibility testing and animal/in-vivo testing, but does not cite specific standards (ISO, ASTM, IEC, etc.).

Substantial equivalence argument

The subject device is substantially equivalent because it matches the predicate devices (BIOFOAM® K142724 and Arthrex BioSync® K151256) in material composition (CP titanium), intended use (foot bone fixation with ancillary fixation), physical properties (porosity 62-66% vs 60-70% and 58%, pore sizes and elastic modulus within equivalent ranges), and performance characteristics (abrasion and friction results equivalent to K151256, fatigue strength equivalent to K151256). No new safety or effectiveness concerns were identified based on the non-clinical testing data provided.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →